UBS Initiates Ahead of STERIS Earnings, Options Turn Bullish
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
STE heads into its August 5 earnings release with analyst sentiment shifting positive and options positioning notably more bullish than usual.
The clearest signal comes from options markets. Call demand has surged relative to puts — the put/call ratio has dropped to 0.28, well below its 20-day average of 0.33 and nearly 1.7 standard deviations on the bullish side. That's a sharp reversal from mid-July, when the PCR was hovering around 0.37. The move coincides with an 8.5% gain in the stock over the past month, closing at $228.40 on July 31, though a 1.2% pullback on the final session of the month suggests some profit-taking into the event.
The analyst backdrop reinforces the bullish lean. UBS initiated coverage on July 28 with a Buy rating and a $275 target — a 20% premium to the current price — just days before the print. That joins an existing consensus of four Buy ratings and a mean target of $255, implying the Street still sees meaningful upside. The bull case rests on organic revenue growth running at 5%, EBIT margins expanding 110 basis points, and EPS up 14% year-on-year in the most recent quarter. Bears focus on a harder-to-ignore problem: capital equipment sales fell roughly 16% year-on-year in F4Q25, service revenues dropped 21%, and the backlog shrank by $66 million — raising the question of whether the consumables and recurring revenue base can compensate for structural weakness in the equipment cycle. The stock's P/E of 19.4x is not stretched for the sector, but the price-to-FCF above 88x leaves little room for a guidance miss.
Short interest tells a far less dramatic story and doesn't change the setup materially. Bears hold just 2.4% of the free float short — a low absolute level — though that position has grown 32% over the past month, the largest chunk arriving in mid-July. Borrow remains cheap at 0.45% and availability is essentially unlimited at 3,600% of shares on loan, meaning there is no squeeze dynamic in the lending market.
The earnings print will therefore test whether the equipment cycle is genuinely troughing or still deteriorating — and whether the organic growth and margin expansion story is durable enough to justify the recent re-rating.
Stocks in this article
See the live data behind this article on ORTEX.
Open STE on ORTEX →How this article was generated
- Generated
- 2 Aug 2026, 04:21
- Data as of
- 2 Aug 2026, 04:04
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.